Cargando…
Telemedicine in Heart Failure in the COVID-19 and Post-Pandemic Era: What Have We Learned?
Numerous studies showed that patients with heart failure (HF) and COVID-19 are at high risk of in-hospital complications and long-term mortality. Changes in the organisation of the medical system during the pandemic also worsened access to standard procedures, increasing the general mortality in HF...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452788/ https://www.ncbi.nlm.nih.gov/pubmed/37626719 http://dx.doi.org/10.3390/biomedicines11082222 |
_version_ | 1785095758953840640 |
---|---|
author | Sokolski, Mateusz Kalużna-Oleksy, Marta Tycińska, Agnieszka Jankowska, Ewa A. |
author_facet | Sokolski, Mateusz Kalużna-Oleksy, Marta Tycińska, Agnieszka Jankowska, Ewa A. |
author_sort | Sokolski, Mateusz |
collection | PubMed |
description | Numerous studies showed that patients with heart failure (HF) and COVID-19 are at high risk of in-hospital complications and long-term mortality. Changes in the organisation of the medical system during the pandemic also worsened access to standard procedures, increasing the general mortality in HF and forcing the systems to be reorganised with the implementation and development of telemedical technologies. The main challenges for HF patients during the pandemic could be solved with new technologies aimed to limit the risk of SARS-CoV-2 transmission, optimise and titrate the therapy, prevent the progression and worsening of HF, and monitor patients with acute HF events in the course of and after COVID-19. Dedicated platforms, phone calls or video conferencing and consultation, and remote non-invasive and invasive cardiac monitoring became potential tools used to meet the aforementioned challenges. These solutions showed to be effective in the model of care for patients with HF and undoubtedly will be developed after the experience of the pandemic. However, the multitude of possibilities requires central coordination and collaboration between institutes with data protection and cost reimbursement to create effective mechanisms in HF management. It is crucial that lessons be learned from the pandemic experience to improve the quality of care for HF patients. |
format | Online Article Text |
id | pubmed-10452788 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-104527882023-08-26 Telemedicine in Heart Failure in the COVID-19 and Post-Pandemic Era: What Have We Learned? Sokolski, Mateusz Kalużna-Oleksy, Marta Tycińska, Agnieszka Jankowska, Ewa A. Biomedicines Review Numerous studies showed that patients with heart failure (HF) and COVID-19 are at high risk of in-hospital complications and long-term mortality. Changes in the organisation of the medical system during the pandemic also worsened access to standard procedures, increasing the general mortality in HF and forcing the systems to be reorganised with the implementation and development of telemedical technologies. The main challenges for HF patients during the pandemic could be solved with new technologies aimed to limit the risk of SARS-CoV-2 transmission, optimise and titrate the therapy, prevent the progression and worsening of HF, and monitor patients with acute HF events in the course of and after COVID-19. Dedicated platforms, phone calls or video conferencing and consultation, and remote non-invasive and invasive cardiac monitoring became potential tools used to meet the aforementioned challenges. These solutions showed to be effective in the model of care for patients with HF and undoubtedly will be developed after the experience of the pandemic. However, the multitude of possibilities requires central coordination and collaboration between institutes with data protection and cost reimbursement to create effective mechanisms in HF management. It is crucial that lessons be learned from the pandemic experience to improve the quality of care for HF patients. MDPI 2023-08-08 /pmc/articles/PMC10452788/ /pubmed/37626719 http://dx.doi.org/10.3390/biomedicines11082222 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Sokolski, Mateusz Kalużna-Oleksy, Marta Tycińska, Agnieszka Jankowska, Ewa A. Telemedicine in Heart Failure in the COVID-19 and Post-Pandemic Era: What Have We Learned? |
title | Telemedicine in Heart Failure in the COVID-19 and Post-Pandemic Era: What Have We Learned? |
title_full | Telemedicine in Heart Failure in the COVID-19 and Post-Pandemic Era: What Have We Learned? |
title_fullStr | Telemedicine in Heart Failure in the COVID-19 and Post-Pandemic Era: What Have We Learned? |
title_full_unstemmed | Telemedicine in Heart Failure in the COVID-19 and Post-Pandemic Era: What Have We Learned? |
title_short | Telemedicine in Heart Failure in the COVID-19 and Post-Pandemic Era: What Have We Learned? |
title_sort | telemedicine in heart failure in the covid-19 and post-pandemic era: what have we learned? |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452788/ https://www.ncbi.nlm.nih.gov/pubmed/37626719 http://dx.doi.org/10.3390/biomedicines11082222 |
work_keys_str_mv | AT sokolskimateusz telemedicineinheartfailureinthecovid19andpostpandemicerawhathavewelearned AT kaluznaoleksymarta telemedicineinheartfailureinthecovid19andpostpandemicerawhathavewelearned AT tycinskaagnieszka telemedicineinheartfailureinthecovid19andpostpandemicerawhathavewelearned AT jankowskaewaa telemedicineinheartfailureinthecovid19andpostpandemicerawhathavewelearned |